Immuron (IMRN) Equity Average (2017 - 2025)

Immuron has reported Equity Average for 9 years, with the latest figure at $2.6 million in Q3 2025.

• For the quarter ending Q3 2025, Equity Average fell 38.28% year-over-year to $2.6 million; the trailing twelve-month figure through Sep 2025 stood at $2.6 million (down 38.28% YoY), and the FY2025 full-year result was $2.7 million, down 37.25% from the prior year.
• Equity Average for Q3 2025 stood at $2.6 million, down from $6.0 million in the prior quarter.
• The five-year high for Equity Average was $15.7 million in Q4 2022, with the low at $236775.3 in Q2 2022.
• Average Equity Average over 5 years is $5.5 million, with a median of $4.2 million recorded in 2024.
• Year-over-year, Equity Average sank 85.51% in 2021 and surged 6160.13% in 2022.
• Tracing IMRN's Equity Average over 5 years: stood at $250363.6 in 2021, then surged by 6160.13% to $15.7 million in 2022, then slumped by 58.62% to $6.5 million in 2023, then sank by 46.9% to $3.4 million in 2024, then retreated by 23.82% to $2.6 million in 2025.
• The last three Equity Average figures came in at $2.6 million (Q3 2025), $6.0 million (Q2 2025), and $3.4 million (Q4 2024), per Business Quant data.

Peer Comparison